[Thrombolysis using tissue-type plasminogen activator and pro-urokinase: synergism; mutants and hybrids].
Páramo
J A
JA
Fernández
F J
FJ
Cuesta
B
B
Paloma
M J
MJ
Rocha
E
E
D004357:Drug Synergism; D005337:Fibrin / Q000378:metabolism; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D010960:Plasminogen Activators / Q000235:genetics / Q000494:pharmacology*; D015202:Protein Engineering; D011993:Recombinant Fusion Proteins / Q000494:pharmacology; D010959:Tissue Plasminogen Activator / Q000235:genetics / Q000494:pharmacology*; D014568:Urokinase-Type Plasminogen Activator / Q000235:genetics / Q000494:pharmacology*
D011993:Recombinant Fusion Proteins; D005337:Fibrin; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator
Trombolisis con activador tisular del plasminógeno y prouroquinasa: sinergismo, mutantes e híbridos.